| 1 |
23856142 | [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs]. | 2013 Mar |
1 |
| 2 |
22031231 | Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival. | 2012 Jan |
4 |
| 3 |
22960937 | A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma. | 2012 Nov |
1 |
| 4 |
20627363 | Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. | 2011 Feb |
1 |
| 5 |
21357891 | Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives. | 2011 Mar |
2 |
| 6 |
20082278 | Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy. | 2009 Oct-Dec |
1 |
| 7 |
21885003 | Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer. | 2008 Mar |
1 |